SCHEMBL8889167

SCHEMBL8889167

COc1cccc(Nc2nc(Nc3cccc(OC)c3)c3ccccc3n2)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 2/20 0.76
HTT P42858 5/20 0.73
KDM4E B2RXH2 3/20 0.73
TAAR1 Q96RJ0 1/20 0.73
ABCG2 Q9UNQ0 9/20 0.73
MEN1 O00255 3/20 0.73
KMT2A Q03164 3/20 0.73
ABCB1 P08183 5/20 0.71
PDE5A O76074 1/20 0.71
DYRK3 O43781 1/20 0.66
MAP4K4 O95819 1/20 0.66
EGFR P00533 1/20 0.66
PDGFRA P16234 1/20 0.66
LTK P29376 1/20 0.66
GRK5 P34947 1/20 0.66
KDR P35968 1/20 0.66
MAPK8 P45983 1/20 0.66
CDK8 P49336 1/20 0.66
CDK7 P50613 1/20 0.66
IRAK1 P51617 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8907425 0.99 HTT (0.75) NPY5RHTTKDM4ETAAR1ABCG2
SCHEMBL8891851 0.99 NPY5R (0.78) NPY5RHTTKDM4ETAAR1ABCG2
Hydrochloric Acid SCHEMBL8899399 0.97 NPY5R (0.76) NPY5RHTTKDM4ETAAR1ABCG2
Hydrochloric Acid SCHEMBL8907334 0.94 NPY5R (0.83) NPY5RHTTKDM4ETAAR1ABCG2
SCHEMBL27465314 0.93 ABCG2 (0.72) NPY5RHTTKDM4ETAAR1ABCG2
SCHEMBL8891079 0.92 NPY5R (0.72) NPY5RHTTKDM4ETAAR1ABCG2
Hydrochloric Acid SCHEMBL8898320 0.91 NPY5R (0.70) NPY5RHTTKDM4ETAAR1ABCG2
SCHEMBL8889905 0.91 NPY5R (0.63) NPY5RHTTKDM4ETAAR1ABCG2
SCHEMBL8891464 0.90 NPY5R (0.69) NPY5RHTTKDM4ETAAR1ABCG2
Hydrochloric Acid SCHEMBL8892216 0.90 HTT (0.64) NPY5RHTTKDM4ETAAR1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed